×
About 29,968 results

ALLMedicine™ Intraocular Pressure Center

Research & Reviews  14,159 results

Five-year results of non-penetrating deep sclerectomy with demineralized cancellous bon...
https://doi.org/10.1007/s10792-021-01760-x 10.1038/eye.2001.60 10.1007/s00417-015-2931-4 10.1001/jamaophthalmol.2013.5059 10.1111/j.1600-0420.2006.00654.x 10.1016/j.exer.2015.03.021 10.1016/j.preteyeres.2009.06.004 10.1016/s0886-3350(99)80079-0 10.1007/BF00212963 10.1097/IJG.0000000000000253 10.1097/IJG.0b013e3181812812 10.1001/archopht.120.3.297 10.3928/1542-8877-20040101-03 10.1097/01.ijg.0000195932.48288.97 10.1097/01.ijg.0000151684.12033.4d 10.1097/IJG.0b013e3182883c0c 10.1016/s0161-6420(02)01069-2 10.1097/IJG.0000000000000720 10.1136/bjo.43.11.641 10.1136/bjo.52.2.157 10.1097/IJG.0000000000000187 10.1097/IJG.0000000000000778 10.1038/s41433-019-0336-z 10.1097/IJG.0000000000001323 10.3129/i10-056 10.1186/s12886-015-0134-8 10.1097/IJG.0b013e318182ed9e 10.1097/IJG.0b013e3181e3d2f7 10.1016/s0002-9394(14)71642-3 10.1016/S0161-6420(98)94033-7 10.1136/bjo.2008.150318 10.1016/s0169-409x(97)00125-7 10.1111/aos.13902 10.1016/0267-6605(92)90093-9 10.1016/j.carbpol.2010.11.009 10.1016/j.ophtha.2013.01.032 10.1111/j.1755-3768.2009.01630.x 10.1097/IJG.0b013e31814b98f7 10.1097/00061198-200208000-00003 10.1177/112067210401400105 10.1111/j.1755-3768.2008.01494.x 10.1038/sj.eye.6701878
International Ophthalmology; Anisimova NS, Arbisser LB et. al.

Mar 3rd, 2021 - To investigate the long-term effectiveness of non-penetrating deep sclerectomy (NPDS) with xenogenically derived cancellous bone collagen glaucoma implant (XCB-CGI) implantation in patients with primary open-angle glaucoma (POAG). Retrospective ch...

How a dynamic optical system maintains image quality: Self-adjustment of the human eye.
https://doi.org/10.1167/jov.21.3.6
Journal of Vision; Józwik A, Asejczyk-Widlicka M et. al.

Mar 3rd, 2021 - The eyeball is continually subjected to forces that cause alterations to its shape and dimensions, as well as to its optical components. Forces that induce accommodation result in an intentional change in focus; others, such as the effect of intra...

Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy ...
https://doi.org/10.1177/1120672121998913
European Journal of Ophthalmology; Mehta AA, Kanu LN et. al.

Mar 3rd, 2021 - To assess the effectiveness and safety of adjunctive topical netarsudil 0.02% and latanoprostene bunod 0.024% in patients with glaucoma. A retrospective, multi-center, cohort study of patients with glaucoma treated with netarsudil 0.02% or latanop...

Adaptive responses to neurodegenerative stress in glaucoma.
https://doi.org/10.1016/j.preteyeres.2021.100953
Progress in Retinal and Eye Research; Calkins DJ

Feb 28th, 2021 - Glaucoma causes loss of vision through degeneration of the retinal ganglion cell (RGC) projection to the brain. The disease is characterized by sensitivity to intraocular pressure (IOP) conveyed through the optic nerve head, through which RGC axon...

see more →

Guidelines  2 results

The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Gla...
https://www.aao.org/ophthalmic-technology-assessment/effect-of-anti-vascular-endothelial-growth-factor-
AAO OTAC Glaucoma Panel

Jan 6th, 2019 - Intravitreal injection of anti-VEGF agents results in an immediate and transient increase in IOP. A long-term increase in IOP also may be seen, and further studies are needed to determine at-risk populations.

Screening for Glaucoma: Clinical Summary of USPSTF Recommendation
https://allmedx.com/USPSTFPDF/glaucomasumm.pdf

Jul 2nd, 2013 - SCREENING FOR GLAUCOMA CLINICAL SUMMARY OF U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATION Population Adults without vision symptoms who are seen in primary care Recommendation No recommendation. Grade: I statement Ris...

see more →

Drugs  441 results see all →

Clinicaltrials.gov  14,983 results

Five-year results of non-penetrating deep sclerectomy with demineralized cancellous bon...
https://doi.org/10.1007/s10792-021-01760-x 10.1038/eye.2001.60 10.1007/s00417-015-2931-4 10.1001/jamaophthalmol.2013.5059 10.1111/j.1600-0420.2006.00654.x 10.1016/j.exer.2015.03.021 10.1016/j.preteyeres.2009.06.004 10.1016/s0886-3350(99)80079-0 10.1007/BF00212963 10.1097/IJG.0000000000000253 10.1097/IJG.0b013e3181812812 10.1001/archopht.120.3.297 10.3928/1542-8877-20040101-03 10.1097/01.ijg.0000195932.48288.97 10.1097/01.ijg.0000151684.12033.4d 10.1097/IJG.0b013e3182883c0c 10.1016/s0161-6420(02)01069-2 10.1097/IJG.0000000000000720 10.1136/bjo.43.11.641 10.1136/bjo.52.2.157 10.1097/IJG.0000000000000187 10.1097/IJG.0000000000000778 10.1038/s41433-019-0336-z 10.1097/IJG.0000000000001323 10.3129/i10-056 10.1186/s12886-015-0134-8 10.1097/IJG.0b013e318182ed9e 10.1097/IJG.0b013e3181e3d2f7 10.1016/s0002-9394(14)71642-3 10.1016/S0161-6420(98)94033-7 10.1136/bjo.2008.150318 10.1016/s0169-409x(97)00125-7 10.1111/aos.13902 10.1016/0267-6605(92)90093-9 10.1016/j.carbpol.2010.11.009 10.1016/j.ophtha.2013.01.032 10.1111/j.1755-3768.2009.01630.x 10.1097/IJG.0b013e31814b98f7 10.1097/00061198-200208000-00003 10.1177/112067210401400105 10.1111/j.1755-3768.2008.01494.x 10.1038/sj.eye.6701878
International Ophthalmology; Anisimova NS, Arbisser LB et. al.

Mar 3rd, 2021 - To investigate the long-term effectiveness of non-penetrating deep sclerectomy (NPDS) with xenogenically derived cancellous bone collagen glaucoma implant (XCB-CGI) implantation in patients with primary open-angle glaucoma (POAG). Retrospective ch...

How a dynamic optical system maintains image quality: Self-adjustment of the human eye.
https://doi.org/10.1167/jov.21.3.6
Journal of Vision; Józwik A, Asejczyk-Widlicka M et. al.

Mar 3rd, 2021 - The eyeball is continually subjected to forces that cause alterations to its shape and dimensions, as well as to its optical components. Forces that induce accommodation result in an intentional change in focus; others, such as the effect of intra...

Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy ...
https://doi.org/10.1177/1120672121998913
European Journal of Ophthalmology; Mehta AA, Kanu LN et. al.

Mar 3rd, 2021 - To assess the effectiveness and safety of adjunctive topical netarsudil 0.02% and latanoprostene bunod 0.024% in patients with glaucoma. A retrospective, multi-center, cohort study of patients with glaucoma treated with netarsudil 0.02% or latanop...

Adaptive responses to neurodegenerative stress in glaucoma.
https://doi.org/10.1016/j.preteyeres.2021.100953
Progress in Retinal and Eye Research; Calkins DJ

Feb 28th, 2021 - Glaucoma causes loss of vision through degeneration of the retinal ganglion cell (RGC) projection to the brain. The disease is characterized by sensitivity to intraocular pressure (IOP) conveyed through the optic nerve head, through which RGC axon...

see more →

News  379 results

Outdoor Intraocular Pressure Screening Clinic Boosts Patient Management During Pandemic
https://www.medscape.com/viewarticle/944057

Jan 13th, 2021 - NEW YORK (Reuters Health) - A drive-through intraocular pressure (IOP) screening clinic minimized COVID-19 exposure for patients and clinicians by enabling eye pressure measurements in a clinic parking lot. Researchers say the protocol is allowing...

Selective Laser Trabeculoplasty's Value Rises During COVID-19
https://www.medscape.com/viewarticle/941990

Dec 8th, 2020 - With the ongoing pandemic, ophthalmologists continue to search for new ways to reduce patient visits and possible virus exposure without sacrificing outcomes. Not surprisingly, monitoring and adjusting eye drop treatments to lower intraocular pres...

Prolonged Prone Ventilation Could Put COVID Patients at Risk for Orbital Compartment Syndrome
https://www.medscape.com/viewarticle/942055

Dec 6th, 2020 - NEW YORK (Reuters Health) - COVID-19 patients who have to remain in a prolonged prone position because of ventilation during intensive care appear to be at risk for elevated intraocular pressure (IOP), a new case series from the U.S. suggests. The...

Extended-Release Glaucoma Drugs Eagerly Anticipated
https://www.staging.medscape.com/viewarticle/941303

Nov 18th, 2020 - Implants designed to release glaucoma drugs over several months are most helpful for patients who are particularly challenged by administering eyedrops, researchers say. The US Food and Drug Administration approved Allergan's bimatoprost implant (...

EMA Panel Backs Roclanda Eyedrops, New Option for Glaucoma
https://www.medscape.com/viewarticle/941062

Nov 15th, 2020 - The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of the fixed-dose combination of latanoprost and netarsudil (Roclanda). The ophthalmic solution is indicated to decrease elevate...

see more →

Patient Education  4 results see all →